ArticleFrontiers in oncology2026

Synergistic toxicity and clinical prioritization of docetaxel combined with nintedanib for non-small cell lung cancer: a real-world safety analysis using the FAERS database.

Qian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.